Acid-suppressive therapy for prophylaxis of stress ulcer bleeding is commonly prescribed for hospitalized patients. Although its use in select, at-risk patients may reduce clinically significant gastrointestinal bleeding, the alteration in gastric pH and composition may place these patients at a higher risk of infection. Although any pharmacologic alteration of the gastric pH and composition is associated with an increased risk of infection, the risk appears to be highest with proton pump inhibitors, perhaps owing to the potency of this class of drugs in increasing the gastric pH. With the increased risk of infection, universal provision of pharmacologic acid suppression to all hospitalized patients, even all critically ill patients, is inappropriate and should be confined to patients meeting specific criteria. Nurses providing care in critical care areas may be instrumental in screening for appropriate use of acid-suppressive therapy and ensuring the drugs are discontinued upon transfer out of intensive care or when risk factors are no longer present.
Skip Nav Destination
Article navigation
1 June 2017
ARTICLE|
June 01 2017
Prophylactic Acid-Suppressive Therapy in Hospitalized Adults: Indications, Benefits, and Infectious Complications
Andrew C. Faust, PharmD, BCPS;
Andrew C. Faust is a critical care clinical pharmacist primarily working in the medical intensive care unit, Department of Pharmacy, Texas Health Presbyterian Hospital Dallas, Dallas, Texas.
Corresponding author: Andrew C. Faust, PharmD, BCPS, Department of Pharmacy, Texas Health Presbyterian Hospital Dallas, Dallas, TX 75231 (email: [email protected]).
Search for other works by this author on:
Kelly L. Echevarria, PharmD, BCPS;
Kelly L. Echevarria, PharmD, BCPS
Kelly L. Echevarria is an infectious diseases and critical care clinical pharmacist, Department of Pharmacy, South Texas Veterans Health Care System, San Antonio, Texas.
Search for other works by this author on:
Rebecca L. Attridge, PharmD, MSc, BCPS;
Rebecca L. Attridge, PharmD, MSc, BCPS
Rebecca L. Attridge is an associate professor, Department of Pharmacy Practice, University of the Incarnate Word Feik School of Pharmacy, and an adjunct assistant professor, Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, UT Health San Antonio, San Antonio, Texas.
Search for other works by this author on:
Lyndsay Sheperd, PharmD, BCPS;
Lyndsay Sheperd, PharmD, BCPS
Lyndsay Sheperd is a critical care clinical pharmacist primarily working in the surgical-trauma intensive care unit, Department of Pharmacy, Texas Health Presbyterian Hospital Dallas, Dallas, Texas.
Search for other works by this author on:
Marcos I. Restrepo, MD
Marcos I. Restrepo, MD
Marcos I. Restrepo is an associate professor in pulmonary and critical care medicine, Department of Medicine, Division of Pulmonary Diseases and Critical Care Medicine, University of Texas Health Science Center at San Antonio, and Veterans Evidence-Based Research Dissemination Implementation Center, South Texas Veterans Health Care System, San Antonio, Texas.
Search for other works by this author on:
Crit Care Nurse (2017) 37 (3): 18–29.
Citation
Andrew C. Faust, Kelly L. Echevarria, Rebecca L. Attridge, Lyndsay Sheperd, Marcos I. Restrepo; Prophylactic Acid-Suppressive Therapy in Hospitalized Adults: Indications, Benefits, and Infectious Complications. Crit Care Nurse 1 June 2017; 37 (3): 18–29. doi: https://doi.org/10.4037/ccn2017720
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access